Table 1 Characteristics of the six trials included in the meta-analysis
Author | Year | Age (Years) | Median follow-up (month) | Total dose/No. of fraction (Dose/Fraction) | No. of patients | |
|---|---|---|---|---|---|---|
| Â | Â | PCI | No PCI | Â | Â | Â |
Gregor [11] | 1997 | 60 (37–79) | 61 (28–76) | 18 | 36 Gy/18 (2 Gy) | 314 |
24 Gy/12 (2 Gy) | ||||||
Laplanche [13] | 1998 | 58 | 57 | - | 24-30Â Gy/8-10 | 211 |
Cao KJ [14] | 2005 | 54.69 ± 7.56 | 55.63 ± 7.29 | 60 | 36-40 Gy/18-20 | 51 |
Slotman [15] | 2007 | 63 (37–75) | 63 (39–75) | 9 | 20-30 Gy/5-12 | 286 |
Schild [8] | 2012 | 63 (34–79) | 63 (37–80) | 72 | 30 Gy/15 (2 Gy) | 739 |
25 Gy/10 (2.5 Gy) | ||||||